Figure 2.
Kaplan–Meier survival curves of two groups of patients with prostate cancer based on LINC01296-expression levels (P=0.01).
Note: Patients with high levels of LINC01296 expression showed reduced biochemical recurrence-free survival times compared with patients with low levels of LINC01296 expression.